A Black Swan in clinical laboratory practice: The analytical error due to interferences in immunoassay methods

Clinical Chemistry and Laboratory Medicine

Volumn 56, Issue 3, 2018, Pages 397-402

  Clerico, Aldo ^a   Belloni, Lucia ^b   Carrozza, Cinzia ^b   Correale, Mario ^c   Dittadi, Ruggero ^d   Dotti, Claudio ^e   Fortunato, Antonio ^f   Vignati, Giulio ^g   Zucchelli, Gian Carlo ^h   Migliardi, Marco ⁱ  

^a SCUOLA SUPERIORE SANT ANNA   (Italy)

^b S MARIA NUOVA HOSPITAL   (Italy)

^c FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^d NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

^e OSPEDALE DELL'ANGELO   (Italy)

^f UOC Patologia Clinica   (Italy)

^g ELAS Italia   (Italy)

^h INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

ⁱ MAURIZIANO HOSPITAL   (Italy)

Author keywords

Bayesian inference analysis; immunoassay methods; interference; patient centered process; quality control indicators; quality control programs; statistical analysis for quality control

Indexed keywords

ANALYTICAL ERROR; ARTICLE; CLINICAL LABORATORY; DIAGNOSTIC ERROR; DIMENSIONAL MEASUREMENT ACCURACY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; IMMUNOASSAY; PATIENT CARE; PRIORITY JOURNAL; QUALITY CONTROL PROCEDURES; LABORATORY TECHNIQUE; QUALITY CONTROL;

CLINICAL LABORATORY TECHNIQUES; DIAGNOSTIC ERRORS; HUMANS; IMMUNOASSAY; QUALITY CONTROL;

EID: 85037827854     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2017-0881     Document Type: Article

References (36)

1. Vogeser M, Seger C. Irregular analytical errors in diagnostic testing-a novel concept. Clin Chem Lab Med 2018;56:386-96.
2. Miller WG, Jones GR, Horowitz GL, Weykamp C. Proficiency testing/ external quality assessment: current challenges and future directions. Clin Chem 2011;57:1670-80.
3. Sturgeon CM, Viljoen A. Analytical error and interference in immunoassay: minimizing risk. Ann Clin Biochem 2011;48:418-32.
4. Ismail AA. Identifying and reducing potentially wrong immunoassay results even when plausible and "not-unreasonable". Adv Clin Chem 2014;66:241-94.
5. Marks V. False-positive immunoassay results: a multicenter survey of erroneous immunoassay results from assays of 74 analytes in 10 donors from 66 laboratories in seven countries. Clin Chem 2002;48:2008-16.
6. Taleb NN. The Black Swan. The impact of the highly improbable. In: Taleb NN, editor. Prologue. London, England: Penguin Books, 2010: pages XXI-XXIII.
7. Plebani M. Analytical quality: an unfinished journey. Clin Chem Lab Med 2018;56:357-9.
8. Ismail AA, Ismail AA, Ismail Y. Probabilistic Bayesian reasoning can help identifying potentially wrong immunoassays results in clinical practice: even when they appear 'not-unreasonable'. Ann Clin Biochem 2011;48:65-71.
9. Bjerner J, Bolstad N, Piehler A. Belief is only half the truth-or why screening for heterophilic antibody interference in certain assays makes double sense. Ann Clin Biochem 2012;49:381-6.
10. Linnet K. A review on the methodology for assessing diagnostic tests. Clin Chem 1988;34:1379-86.
11. Emerson JF, Ngo G, Emerson SS. Screening for interference in immunoassays. Clin Chem 2003;49:1163-9.
12. Span PN, Grebenchtchikov N, Geurts-Moespot J, Sweep CG. Screening for interference in immunoassays. Clin Chem 2003;49:1708-9.
13. Kricka LJ. Human anti-animal antibody interferences in immunological assays. Clin Chem 1999;45:942-56.
14. Selby C. Interference in immunoassay. Ann Clin Biochem 1999;36:704-21.
15. Bjerner J, Nustad K, Norum LF, Olsen KH, Børmer OP. Immunometric assay interference: incidence and prevention. Clin Chem 2002;48:613-21.
16. Beltran L, Fahie-Wilson MN, McKenna TJ, Kavanagh L, Smith TP. Serum total prolactin and monomeric prolactin reference intervals determined by precipitation with polyethylene glycol: evaluation and validation on common immunoassay platforms. Clin Chem 2008;54:1673-81.
17. Clerico A, Plebani M. Biotin interference on immunoassay methods: sporadic cases or hidden epidemic? Clin Chem Lab Med 2017;55:777-9.
18. Clerico A, Passino C, Franzini M, Emdin M. Cardiac biomarker testing in the clinical laboratory: where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. Clin Chim Acta 2015;443:17-24.
19. Clerico A, Zaninotto M, Prontera C, Giovannini S, Ndreu R, Franzini M, et al. State of the art of BNP and NT-proBNP immunoassays: the CardioOrmoCheck study. Clin Chim Acta 2012;414:112-9.
20. Clerico A, Ripoli A, Masotti S, Prontera C, Storti S, Fortunato A, et al. Pilot study on harmonization of cardiac troponin I immunoassays using patients and quality control plasma samples. On behalf of the Italian Section of the European Ligand Assay Society (ELAS) and of the Study Group on Cardiovascular Biomarkers of the Società Italiana di Biochimica Clinica (SIBioC). Clin Chem Acta 2016;456:42-8.
21. Dittadi R, Rizzardi S, Masotti S, Prontera C, Ripoli A, Fortunato A, et al. Italian Section of the European Ligand Assay Society (ELAS). Multicenter evaluation of the new immunoassay method for TSH measurement using the automated DxI platform. Clin Chim Acta 2017;468:105-10.
22. Sturgeon CM, Berger P, Bidart JM, Birken S, Burns C, Norman RJ, et al. Differences in recognition of the 1st WHO international reference reagents for hCG-related isoforms by diagnostic immunoassays for human chorionic gonadotropin. Clin Chem 2009;55:1484-91.
23. Sturgeon CM, Duffy MJ, Stenman UH, Lilja H, Brünner N, Chan DW, et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. Clin Chem 2008;54:e11-79.
24. Bolstad N, Warren DJ, Nustad K. Heterophilic antibody interference in immunometric assays. Best Pract Res Clin Endocrinol Metab 2013;27:647-61.
25. Preissner CM, Dodge LA, O'Kane DJ, Singh RJ, Grebe SK. Prevalence of heterophilic antibody interference in eight automated tumor marker immunoassays. Clin Chem 2005;51:208-10.
26. Hallworth MJ, Epner PL, Ebert C, Fantz CR, Faye SA, Higgins TN, et al. IFCC task force on the impact of Laboratory Medicine on Clinical Management and Outcomes. Current evidence and future perspectives on the effective practice of patient-centered laboratory medicine. Clin Chem 2015;61:589-99.
27. Committee on Diagnostic Error in Health Care, Board on Health Care Services, Institute of Medicine, The National Academies of Sciences, Engineering, and Medicine, Balogh EP, Miller BT, et al, editors. Improving diagnosis in health care. Washington (DC): National Academies Press (US), 2015.
28. Thienpont LM, Van Uytfanghe K, DeGrande LA, Reynders D, Das B, Faix JD, et al. on behalf for the IFCC Committee for Standardization of Thyroid Function Tests (C-STFT). Harmonization of serum thyroid-stimulating hormone measurements paves the way for the adoption of a common reference interval-A technical report. Clin Chem 2017;63:1248-60.
29. Berger P, Lapthorn AJ. The molecular relationship between antigenic domains and epitopes on hCG. Mol Immunol 2016;76:134-45.
30. Prontera C, Zaninotto M, Giovannini S, Zucchelli GC, Pilo A, Sciacovelli L, et al. Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmocheck study. Clin Chem Lab Med 2009;47:762-8.
31. Zhang K, Huo H, Lin G, Yue Y, Wang Q, Li J. A long way to go for the harmonization of four immunoassays for carcinoembryonic antigen. Clin Chim Acta 2016;454:15-9.
32. Kort SA, Martens F, Vanpoucke H, van Duijnhoven HL, Blankenstein MA. Comparison of 6 automated assays for total and free prostate-specific antigen with special reference to their reactivity toward the WHO 96/670 reference preparation. Clin Chem 2006;52:1568-74.
33. Klee EW, Bondar OP, Goodmanson MK, Trushin SA, Singh RJ, Anderson NL, et al. Mass spectrometry measurements of prostate-specific antigen (PSA) peptides derived from immuneextracted PSA provide a potential strategy for harmonizing immunoassay differences. Am J Clin Pathol 2014;141:527-33.
34. Plebani M. The quality indicator paradox. Clin Chem Lab Med 2016;54:1119-22.
35. Iervasi G, Clerico A, Bonini R, Manfredi C, Berti S, Ravani M, et al. Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia. J Clin Endocrinol Metab 1997;82:275-80.
36. Dinis-Oliveira RJ. Heterogeneous and homogeneous immunoassays for drug analysis. Bioanalysis 2014;6:2877-96.